Search clinical trials for: Low risk prostate cancer

Total 117640 results

Samsung Medical Center

Recruiting

Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy With SPACEOAR TM for Patients With Low-to-intermediate Risk Localized Prostate Cancer (DESAR-L) (DESAR-L)

Low-to-intermediate-risk Prostate Carcinoma

Korea, Republic of
British Columbia Cancer Agency
University of British Columbia; Vancouver Prostate Centre; BC Cancer Foundation

Recruiting

Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer (BrachyTRACKS)

Localized Prostate Carcinoma

Canada
NHS Lothian

Not yet recruiting

The PRECISION Study: 3 Fractions of Prostate SBRT and RayPilot HypoCath Image Guidance (PRECISION)

Low Risk Prostate Cancer | Intermediate Risk Prostate Cancer | Localized Prostate Cancer
Anhui Provincial Hospital
Zhongda Hospital; Yijishan Hospital of Wannan Medical College; Wuhu City Second...

Recruiting

Conducting Active Surveillance Without Prostate Biopsy for Patients With Low-risk Suspected Prostate Cancer (ASWBP)

Prostate Cancer

China
Fondazione del Piemonte per l'Oncologia

Recruiting

Robotic Hemi-Prostatectomy With Urethral Preservation in Low and Intermediate Risk Monolateral Prostate Cancer (RETURN)

Prostate Cancer

Italy
Genesis Research LLC

Recruiting

Investigator Initiated Trial to Further Evaluate the Safety and Efficacy of Trans-perineal Focal Laser Ablation of Localized Prostate Cancer Using High Frequency Micro-ultrasound Imaging

Prostate Cancer | Low-risk or Favorable Intermediate Risk Prostate Cancer Who Are on an Active Surveillance Regimen

United States
San Carlo di Nancy Hospital
Elesta S.R.L.

Recruiting

Transperineal Laser Ablation for Low- and Intermediate Risk Prostate Cancer: a Single Cohort Analysis

Prostate Cancer

Italy
Xiangya Hospital of Central South University

Recruiting

A Study of 68Ga-GRP PET/CT for Imaging in Low and Intermediate Risk Prostate Cancer

Prostate Cancer

China
NRG Oncology
National Cancer Institute (NCI)

Recruiting

Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score

Prostate Adenocarcinoma

United States, Canada
Weill Medical College of Cornell University
Progenics Pharmaceuticals, Inc.; Viewray Inc.

Recruiting

Randomized Trial of Five or Two MRI-Guided Adaptive Radiotherapy Treatments for Prostate Cancer (FORT)

Prostate Cancer

United States, United Kingdom
Daniel George, MD
Merck Sharp & Dohme LLC

Not yet recruiting

Trimodality Approach of Low Dose iOnizing Radiation With or Without Neoadjuvant Pembrolizumab and Prostatectomy for Men With Intermediate/High Risk Prostate Cancer (TALON) (TALON)

Prostate Cancer

United States
NRG Oncology
National Cancer Institute (NCI)

Recruiting

Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial

Prostate Adenocarcinoma | Metastatic Malignant Neoplasm in the Bone | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8

United States, Canada
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI); Seagen Inc.

Recruiting

T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial

Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC... and other conditions

United States, Canada, Puerto Rico
I.M. Sechenov First Moscow State Medical University
Pirogov Russian National Research Medical University; Moscow Regional Research...

Recruiting

Active Surveillance for Low Risk Prostate Cancer

Prostate Cancer | Prostate Adenocarcinoma

Russian Federation
University of Rome Tor Vergata

Recruiting

Focal Laser Ablation for the Treatment of Focal Low-Intermediate Risk Prostate Cancer

Prostate Cancer

Italy
Center Eugene Marquis

Recruiting

Erectile Dysfunction in Good Prognosis Prostate Cancer : Comparison Between Brachytherapy and Stereotactic Body Radiotherapy (TEMPOS)

Prostate Cancer

France
National Taiwan University Hospital

Recruiting

Identify Genes/Pathways Responsible for Progression From Low Risk to Higher Risk Prostate Cancer

Prostate Cancer Stage I

Taiwan
University of Texas Southwestern Medical Center

Recruiting

Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance

Prostate Cancer

United States
EBG MedAustron GmbH

Recruiting

Spot-Scanning Based Hypofractionated Proton Therapy for Low and Intermediate Risk Prostate Cancer

Low Risk Prostate Cancer | Intermediate Risk Prostate Cancer

Austria
British Columbia Cancer Agency
BC Cancer Foundation

Recruiting

LDR vs. HDR Brachytherapy for Prostate Cancer (LDR/HDRmono)

Prostate Cancer

Canada
Seoul National University Hospital

Recruiting

Seoul National University Prospectively Enrolled Registry for Prostate Cancer With Active Surveillance (SUPER-PC-AS)

Prostate Cancer

Korea, Republic of
Fundación Instituto Valenciano de Oncología

Recruiting

Spanish Urological Association Registry of Patients on Active Surveillance

Prostate Cancer

Spain
Regina Elena Cancer Institute
Azienda Sanitaria-Universitaria Integrata di Udine; San Giovanni Addolorata...

Recruiting

A Phase I-II Study on Stereotactic Body Radiotherapy in 3 Fractions for Low/Int Risk Prostate Cancer (eHYPO)

Prostate Cancer

Italy
University of Erlangen-Nürnberg Medical School

Recruiting

Focal Brachytherapy in Patients With Selected "Low-risk" Prostate Cancer - a Phase-II-trial (FOKAL-BT)

Prostate Cancer

Germany
Provision Center for Proton Therapy
Center for Biomedical Research, LLC

Recruiting

Hypofractionated Image Guided Proton Therapy for Low andIntermediate Risk Prostate Cancer

Prostate Cancer

United States
Jonsson Comprehensive Cancer Center

Recruiting

Active Surveillance for Cancer of the Prostate (ASCaP) (ASCaP)

Prostate Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Validation Study on the Impact of Decipher® Testing - VANDAAM Study (VANDAAM)

Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute

Active, not recruiting

Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma

Prostate Cancer

United States
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI)

Completed

Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot Study

Prostate Cancer

United States
Proton Collaborative Group

Active, not recruiting

Study of Hypo-fractionated Proton Radiation for Low Risk Prostate Cancer

Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center
Icahn School of Medicine at Mount Sinai

Active, not recruiting

Decision Making in Men With Early Stage Prostate Cancer Patients and Partners/Close Allies

Low Risk Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer

Prostate Cancer

United States
UNC Lineberger Comprehensive Cancer Center

Withdrawn

PSMA-PET/MRI Low- and Intermediate-Risk Prostate Cancer

Prostate Cancer

United States
VA Office of Research and Development
Medical University of South Carolina

Completed

Vitamin D3 Supplementation for Low-Risk Prostate Cancer: A Randomized Trial (VD3PCa)

Prostate Cancer

United States
Hospices Civils de Lyon

Active, not recruiting

Phase 3, Multicenter, Randomized Study, Evaluating the Efficacy and Tolerability of Focused HIFU (High Intensity Focused Ultrasound) Therapy Compared to Active Surveillance in Patients With Significant Low Risk Prostate Cancer (HIFUSA)

Prostate Cancer

France
CSSS de Gatineau

Active, not recruiting

Study of High-dose Rate (HDR) Monotherapy for Low and Intermediate Risk Prostate Cancer

Prostate Cancer

Canada
SWOG Cancer Research Network
National Cancer Institute (NCI)

Active, not recruiting

S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery

Recurrent Colon Carcinoma | Recurrent Rectal Carcinoma | Rectal Adenocarcinoma | Colon Adenocarcinoma | ERBB2 Gene Amplification | Stage III Colon Cancer AJCC v7 | Stage III Rectal Cancer AJCC v7 | Stage IIIA Colon Cancer AJCC v7 | Stage IIIA Rectal Cancer AJCC v7 | Stage IIIB Colon Cancer AJCC v7 | Stage... and other conditions

United States, Puerto Rico
Royal Marsden NHS Foundation Trust
The Institute of Cancer Research, Sutton, Surrey, UK

Active, not recruiting

Prostate Advances in Comparative Evidence (PACE)

Prostate Cancer

New Zealand, Ireland, United Kingdom, Canada
University Health Network, Toronto
Princess Margaret Hospital, Canada

Active, not recruiting

Advanced Imaging for Radiotherapy Treatment Planning and Guidance for Low-Intermediate Risk Prostate Cancer (Margin)

Low or Intermediate Risk Prostate Cancer

Canada
University of Chicago

Completed

A Randomized Study of Testosterone Replacement in Patients With Low Risk Hormone Refractory Prostate Cancer

Prostate Cancer

United States
Massachusetts General Hospital
National Cancer Institute (NCI); Mayo Clinic; University of Pennsylvania; Washington... and other collaborators

Active, not recruiting

Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer (PARTIQoL)

Prostate Cancer

United States
University of Florida

Active, not recruiting

Hypofractionated Proton Radiation Therapy for Low and Intermediate Risk Prostate Cancer (PR07)

Prostate Cancer

United States
University of Florida

Completed

Proton Therapy for Low and Intermediate Risk Prostate Cancer (PR04)

Prostate Cancer

United States
Mayo Clinic

Active, not recruiting

Proton-Based Stereotactic Ablative Body Radiotherapy for Prostate Cancer

Prostate Cancer

United States
British Columbia Cancer Agency

Active, not recruiting

Comparison of HDR vs. LDR Brachytherapy as Monotherapy for Intermediate Risk Prostate Cancer

Prostate Cancer

Canada
Accuray Incorporated

Completed

CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry

Prostatic Neoplasms | Prostate Cancer | Prostate Neoplasms | Cancer of the Prostate | Prostatic Cancer

United States
Rete Oncologica Piemonte, Valle d'Aosta
Azienda Ospedaliera Città della Salute e della Scienza di Torino; Compagnia...

Completed

Active Surveillance or Radical Treatment for Newly Diagnosed Patients With a Localized, Low Risk, Prostate Cancer START (START)

Prostatic Neoplasm

Italy
Janssen Research & Development, LLC

Completed

A Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone-Naive Prostate Cancer (mHNPC)

Prostate Neoplasms

Canada, France, Poland, Ukraine, United Kingdom, China, Belgium, Spain, Argentina, Colombia, Israel, Mexico, Portugal, Bulgaria, Germany, Malaysia, Romania, South Africa, Turkey, Korea, Republic of, Japan, Australia, Netherlands, Sweden, New Zealand and more
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Terminated

Diet and Exercise Program to Promote Weight Loss and Improve Health in Men With Low- or Low-Intermediate-Risk Prostate Cancer (PALS)

Prostate Adenocarcinoma | Stage I Prostate Cancer AJCC V7 | Stage IIA Prostate Cancer AJCC v7

United States
Mansoura University

Active, not recruiting

Transurethral Prostate Enucleation in Surveillance Protocol for Low Risk Prostate Cancer

Bladder Outlet Obstruction | Prostate Cancer Stage I

Egypt

Search clinical trials for: Low risk prostate cancer

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations